CIK 0001841387 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Candel Therapeutics, Inc.
Sign in to watch- Ticker
- CADL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522214851
- Phone
- 617-916-5445
- Business address
- 117 KENDRICK STREET, SUITE 450, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,244,783
- in 2 filings, $3.2M under 10b5-1 plans
Net −$3,244,783. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-12 | Tak Paul Peter Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +525,000 | 525,000 | ||
| 2025-02-12 | Barone Francesca Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2025-02-10 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | −31,335 | $8.61 | $270K | 60,000 |
| 2025-01-15 | Tyagarajan Seshu Chief Technology Officer | Sale | −14,322 | $7.23 | $103K | 96,790 |
| 2025-01-15 | Barone Francesca Chief Scientific Officer | Sale | −13,534 | $7.23 | $98K | 110,673 |
| 2025-01-15 | Schoch Charles See Remarks | Sale | −9,511 | $7.23 | $69K | 43,038 |
| 2025-01-15 | Tak Paul Peter Chief Executive Officer | Sale | −21,704 | $7.23 | $157K | 251,912 |
| 2025-01-15 | Nichols William Garrett Chief Medical Officer | Sale | −10,428 | $7.23 | $75K | 79,320 |
| 2025-01-08 | Barone Francesca Chief Scientific Officer | Sale | −13,673 | $8.22 | $112K | 124,207 |
| 2025-01-08 | Schoch Charles See Remarks | Sale | −9,971 | $8.22 | $82K | 52,549 |
| 2025-01-08 | Tak Paul Peter Chief Executive Officer | Sale | −21,172 | $8.22 | $174K | 273,616 |
| 2025-01-08 | Tyagarajan Seshu Chief Technology Officer | Sale | −14,545 | $8.22 | $120K | 111,112 |
| 2025-01-08 | Nichols William Garrett Chief Medical Officer | Sale | −10,799 | $8.22 | $89K | 89,748 |
| 2024-12-27 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | −50,000 | $8.85 | $443K | 173,512 |
| 2024-12-27 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | −50,000 | $8.85 | $443K | 131,443 |
| 2024-12-26 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | −50,000 | $9.01 | $451K | 223,512 |
| 2024-12-26 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | −50,000 | $9.01 | $451K | 181,443 |
| 2024-12-24 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | +50,000 | $8.82 | $441K | 273,512 |
| 2024-12-24 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | −50,000 | $8.82 | $441K | 231,443 |
| 2024-12-23 | Aguilar-Cordova Estuardo 10% owner | Returned to the company | −50,000 | $8.52 | $426K | 323,512 |
Page 5 of 13 · 249 trades